54gene

Founded by Dr. Abasi Ene-Obong in 2019, 54gene is a pioneering biotechnology company focused on genomic research in Africa. The startup is working to bridge the gap in global genomics by studying African DNA to uncover valuable insights for precision medicine. Africa represents over 20% of the world's genetic diversity, yet its population has been vastly underrepresented in global genetic research. 54gene aims to change that by building biobanks, genomic databases, and research collaborations with pharmaceutical companies, hospitals, and academic institutions. The company's long-term goal is to create personalized healthcare solutions tailored to African populations, addressing diseases like cancer, sickle cell anemia, and cardiovascular conditions.